AIDS Vaccine Tests Set for Thailand, Brazil

var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); ion" CONTENT="Newly appointed leader of the United Nations AIDS program, Dr. Peter Piot, announced on Friday that heterosexual male drug users in Thailand and homosexual men in Brazil will be the key volunteers of the first human tests of two AIDS vaccines. Women will also be included in the initial tests, particularly in northern T"> AIDS Vaccine Tests Set for Thailand, Brazil < > // var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); > < > // var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); >

Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

AIDS Vaccine Tests Set for Thailand, Brazil

Boston Globe (12/17/94) P. 15

Newly appointed leader of the United Nations AIDS program, Dr. Peter Piot, announced on Friday that heterosexual male drug users in Thailand and homosexual men in Brazil will be the key volunteers of the first human tests of two AIDS vaccines. Women will also be included in the initial tests, particularly in northern Thailand. The World Health Organization (WHO) recently completed a master plan for the tests of two vaccines, said Piot. While other vaccines are being developed, they are still only in the laboratory or are being tested on animals and will not be tested on humans for years, he added. WHO said that the test groups were selected because they were very likely to be exposed to a strain of HIV for which a vaccine had been developed, and also because researchers could track them. Christopher Powell, spokesman for WHO's Global Program on AIDS, said that the vaccines to be tested, called GP-120, were safe to use on humans and had already been tested in small-scale trials in the United States and Europe. The vaccines, Powell said, produce a limited number of antibodies and do not have a long-lasting effect.

941219
AD942260

Copyright © 1994 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Elton John AIDS Foundation, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .